Evidence map›Paper›PMID 36873885›Full record

ReviewFrontiers in medicine2023

Neutrophil extracellular traps in central nervous system pathologies: A mini review.

Areez Shafqat, Ahmed Noor Eddin, Ghaith Adi, Mohammed Al-Rimawi, Saleha Abdul Rab, Mylia Abu-Shaar, Kareem Adi, Khaled Alkattan, Ahmed Yaqinuddin

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. NETosis: A key player in autoimmunity, COVID-19, and long COVID.Journal of translational autoimmunity · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Areez ShafqatCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Ahmed Noor EddinCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Ghaith AdiCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Mohammed Al-RimawiCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Saleha Abdul RabCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Mylia Abu-ShaarCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Kareem AdiCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Khaled AlkattanCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Ahmed YaqinuddinCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Alfaisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils are the first cells to be recruited to sites of acute inflammation and contribute to host defense through phagocytosis, degranulation and neutrophil extracellular traps (NETs). Neutrophils are rarely found in the brain because of the highly selective blood-brain barrier (BBB). However, several diseases disrupt the BBB and cause neuroinflammation. In this regard, neutrophils and NETs have been visualized in the brain after various insults, including traumatic (traumatic brain injury and spinal cord injury), infectious (bacterial meningitis), vascular (ischemic stroke), autoimmune (systemic lupus erythematosus), neurodegenerative (multiple sclerosis and Alzheimer's disease), and neoplastic (glioma) causes. Significantly, preventing neutrophil trafficking into the central nervous system or NET production in these diseases alleviates brain pathology and improves neurocognitive outcomes. This review summarizes the major studies on the contribution of NETs to central nervous system (CNS) disorders.

Indexed as

Alzheimer’s diseaseblood-brain barrierneurodegenerationneuroinflammationneutrophil extracellular trapsneutrophils (PMNs)stroketraumatic brain injury

Identifiers

PMID36873885
PMCPMC9981681
OpenAlexW4321238640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.